Skip Navigation

JNCI Journal of the National Cancer Institute 2007 99(23):1737; doi:10.1093/jnci/djm256
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Japanese Translation
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2007.

IN THIS ISSUE

The first 10% of the full text of this article appears below.

Evidence on Use of PET in Lung Cancer Diagnosis and Staging

Tumor imaging with 18fluorodeoxyglucose positron emission tomography, or PET, has the potential to improve the clinical management of patients with lung cancer. Ung et al. (p. 1753) identified studies that have provided evidence about the use of PET in lung cancer diagnosis and staging. Their systematic review indicates that PET has high sensitivity and reasonable specificity for distinguishing between benign and malignant lesions and that it is better than computed tomography for staging mediastinal tumors in non–small-cell lung cancer. PET also appears to have good accuracy in staging . . . [Full Text of this Article]

Invasive Breast Cancer Risk Models in African American Women

Tumor Microenvironment and Efficacy of Oncolytic Virus Therapy

Carbohydrates, Insulin Levels, and Prostate Tumor Growth

Distinct Etiology of HPV16-Associated Head and Neck Cancers

Breast Cancer Risk Among Male BRCA1, BRCA2 Mutation Carriers


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

Breast Cancer Risk Among Male BRCA1 and BRCA2 Mutation Carriers
Yu Chuan Tai, Susan Domchek, Giovanni Parmigiani, and Sining Chen
J Natl Cancer Inst 2007 99: 1811-1814. [Abstract] [Full Text] [PDF]

Projecting Individualized Absolute Invasive Breast Cancer Risk in African American Women
Mitchell H. Gail, Joseph P. Costantino, David Pee, Melissa Bondy, Lisa Newman, Mano Selvan, Garnet L. Anderson, Kathleen E. Malone, Polly A. Marchbanks, Worta McCaskill-Stevens, Sandra A. Norman, Michael S. Simon, Robert Spirtas, Giske Ursin, and Leslie Bernstein
J Natl Cancer Inst 2007 99: 1782-1792. [Abstract] [Full Text] [PDF]

Effect of Tumor Microenvironment Modulation on the Efficacy of Oncolytic Virus Therapy
Kazuhiko Kurozumi, Jayson Hardcastle, Roopa Thakur, Ming Yang, Gregory Christoforidis, Giulia Fulci, Fred H. Hochberg, Ralph Weissleder, William Carson, E. Antonio Chiocca, and Balveen Kaur
J Natl Cancer Inst 2007 99: 1768-1781. [Abstract] [Full Text] [PDF]

Association of Diet-Induced Hyperinsulinemia With Accelerated Growth of Prostate Cancer (LNCaP) Xenografts
Vasundara Venkateswaran, Ahmed Q. Haddad, Neil E. Fleshner, Rong Fan, Linda M. Sugar, Rob Nam, Laurence H. Klotz, and Michael Pollak
J Natl Cancer Inst 2007 99: 1793-1800. [Abstract] [Full Text] [PDF]

18Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis and Staging of Lung Cancer: A Systematic Review
Yee C. Ung, Donna E. Maziak, Jessica A. Vanderveen, Christopher A. Smith, Karen Gulenchyn, Christina Lacchetti, William K. Evans, and Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care
J Natl Cancer Inst 2007 99: 1753-1767. [Abstract] [Full Text] [PDF]

Lack of Association of Alcohol and Tobacco with HPV16-Associated Head and Neck Cancer
Katie M. Applebaum, C. Sloane Furniss, Ariana Zeka, Marshall R. Posner, Judith F. Smith, Janine Bryan, Ellen A. Eisen, Edward S. Peters, Michael D. McClean, and Karl T. Kelsey
J Natl Cancer Inst 2007 99: 1801-1810. [Abstract] [Full Text] [PDF]

Targeting the Tumor Vasculature to Improve the Efficacy of Oncolytic Virus Therapy
Jung Hyo Rhim and Giovanna Tosato
J Natl Cancer Inst 2007 99: 1739-1741. [Extract] [Full Text] [PDF]

18Fluorodeoxyglucose Positron Emission Tomography, a Standard Diagnostic Tool in Lung Cancer
Giuseppe Giaccone
J Natl Cancer Inst 2007 99: 1741-1743. [Extract] [Full Text] [PDF]